Affordable Access

Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups.

Authors
  • Utkan, Güngör
  • Ürün, Yüksel
  • Cangir, Ayten Kayi
  • Kılıç, Dalokay
  • Özdemir, Nuriye Yildirim
  • Oztuna, Derya Gokmen
  • Bulut, Erhan
  • Arslan, Ülkü Yalçintaş
  • Koçer, Murat
  • Kavukçu, Şevket
  • İçli, Fikri
Type
Published Article
Journal
Asian Pacific journal of cancer prevention : APJCP
Publication Date
Jan 01, 2013
Volume
14
Issue
1
Pages
249–253
Identifiers
PMID: 23534732
Source
Medline
License
Unknown

Abstract

The results of this study suggest that patients with MM can benefit from treatment with pemetrexed or gemcitabine in combination with cisplatin. We did not observe a statistically significant association between ABO blood group and risk of MM.

Report this publication

Statistics

Seen <100 times